Pomanda estimates the enterprise value of MEDANNEX LIMITED at £1.7m based on a Turnover of £1.3m and 1.37x industry multiple (adjusted for size and gross margin).
medannex limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of MEDANNEX LIMITED at £0 based on an EBITDA of £-2.1m and a 5.39x industry multiple (adjusted for size and gross margin).
medannex limitedEstimated Valuation
£1.7m
Pomanda estimates the enterprise value of MEDANNEX LIMITED at £1.7m based on Net Assets of £969.5k and 1.79x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Medannex LimitedOverview
Medannex Limited is a live company located in edinburgh, EH3 9QA with a Companies House number of SC363190. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in July 2009, it's largest shareholder is
morningside venture investments limited
with a 31.1% stake. Medannex Limited is a established,
small sized company, Pomanda has estimated its turnover at
£1.3m with
high
growth in recent years.
Pomanda's financial health check has awarded Medannex Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
3 Strong
3 Regular
4 Weak
Size
annual sales of £1.3m, make it smaller than the average company (£4.7m)
£1.3m - Medannex Limited
£4.7m - Industry AVG
Growth
3 year (CAGR) sales growth of 18%, show it is growing at a faster rate (13.8%)
18% - Medannex Limited
13.8% - Industry AVG
Production
with a gross margin of 56%, this company has a comparable cost of product (56%)
56% - Medannex Limited
56% - Industry AVG
Profitability
an operating margin of -167.9% make it less profitable than the average company (-3.9%)
-167.9% - Medannex Limited
-3.9% - Industry AVG
Employees
with 12 employees, this is below the industry average (48)
12 - Medannex Limited
48 - Industry AVG
Pay Structure
on an average salary of £82.8k, the company has an equivalent pay structure (£82.8k)
£82.8k - Medannex Limited
£82.8k - Industry AVG
Efficiency
resulting in sales per employee of £105.5k, this is less efficient (£130.9k)
£105.5k - Medannex Limited
£130.9k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Medannex Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 146 days, this is slower than average (57 days)
146 days - Medannex Limited
57 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Medannex Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 34 weeks, this is average cash available to meet short term requirements (34 weeks)
34 weeks - Medannex Limited
34 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 31.6%, this is a lower level of debt than the average (49.5%)
31.6% - Medannex Limited
49.5% - Industry AVG
MEDANNEX LIMITED financials
EXPORT
Medannex Limited's latest turnover from September 2024 is estimated at £1.3 million and the company has net assets of £969.5 thousand. According to their latest financial statements, Medannex Limited has 12 employees and maintains cash reserves of £293.3 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Jul 2013
Jul 2012
Jul 2011
Jul 2010
Turnover
1,265,788
1,874,887
2,142,028
775,131
893,194
295,882
435,062
398,269
255,938
148,950
245,565
726,570
133,069
1,152
Other Income Or Grants
Cost Of Sales
556,899
871,300
1,033,795
383,436
426,775
144,470
208,339
189,859
132,500
77,943
127,486
393,688
71,036
571
Gross Profit
708,889
1,003,588
1,108,233
391,696
466,419
151,412
226,723
208,410
123,439
71,007
118,079
332,882
62,032
581
Admin Expenses
2,833,656
2,930,954
3,754,405
3,434,671
4,001,076
1,246,353
522,080
666,884
426,158
416,436
389,508
407,246
181,201
88,418
Operating Profit
-2,124,767
-1,927,366
-2,646,172
-3,042,975
-3,534,657
-1,094,941
-295,357
-458,474
-302,719
-345,429
-271,429
-74,364
-119,169
-87,837
Interest Payable
Interest Receivable
22,920
20,399
24,233
4,294
5,660
18,191
1,706
1,454
1,062
790
784
53
1
Pre-Tax Profit
-2,101,847
-1,906,967
-2,621,939
-3,038,681
-3,528,997
-1,076,750
-293,651
-457,020
-301,657
-344,639
-270,645
-74,311
-119,169
-87,837
Tax
Profit After Tax
-2,101,847
-1,906,967
-2,621,939
-3,038,681
-3,528,997
-1,076,750
-293,651
-457,020
-301,657
-344,639
-270,645
-74,311
-119,169
-87,837
Dividends Paid
Retained Profit
-2,101,847
-1,906,967
-2,621,939
-3,038,681
-3,528,997
-1,076,750
-293,651
-457,020
-301,657
-344,639
-270,645
-74,311
-119,169
-87,837
Employee Costs
993,162
980,521
1,026,459
991,082
606,326
331,974
318,190
274,908
172,029
107,004
158,536
406,824
103,633
53,212
Number Of Employees
12
13
14
14
9
5
5
5
3
2
3
8
2
1
EBITDA*
-2,105,362
-1,912,005
-2,634,474
-3,034,797
-3,526,798
-1,088,717
-290,356
-454,154
-300,169
-343,823
-270,207
-74,150
-119,169
-87,837
* Earnings Before Interest, Tax, Depreciation and Amortisation
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Jul 2013
Jul 2012
Jul 2011
Jul 2010
Tangible Assets
1,396
1,745
2,180
2,725
2,453
3,066
593
741
Intangible Assets
740,893
659,618
604,257
559,151
230,321
213,074
219,090
208,288
202,443
177,908
109,807
79,150
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
742,289
661,363
606,437
561,876
232,774
216,140
219,683
209,029
202,443
177,908
109,807
79,150
Stock & work in progress
Trade Debtors
5,939
1,920
1,250
304
38,297
34,517
20,907
Group Debtors
Misc Debtors
381,197
576,386
2,153,642
1,808,321
1,001,074
151,929
114,666
71,455
4,506
Cash
293,259
623,554
153,566
2,000,508
6,587,074
4,733,823
117,223
337,720
825,858
23,723
292,249
21,162
100
100
misc current assets
total current assets
674,456
1,199,940
2,307,208
3,814,768
7,590,068
4,887,002
231,889
409,175
830,364
24,027
330,546
55,679
21,007
100
total assets
1,416,745
1,861,303
2,913,645
4,376,644
7,822,842
5,103,142
451,572
618,204
1,032,807
201,935
440,353
134,829
21,007
100
Bank overdraft
Bank loan
Trade Creditors
223,641
859,639
935,986
110,882
690,317
87,537
40,983
27,021
58,243
149,407
43,186
416,046
9,543
399
Group/Directors Accounts
218,370
87,438
other short term finances
hp & lease commitments
other current liabilities
223,645
843,037
794,066
460,230
288,312
142,707
13,208
25,151
126,512
total current liabilities
447,286
1,702,676
1,730,052
571,112
978,629
230,244
54,191
52,172
184,755
149,407
43,186
416,046
227,913
87,837
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
447,286
1,702,676
1,730,052
571,112
978,629
230,244
54,191
52,172
184,755
149,407
43,186
416,046
227,913
87,837
net assets
969,459
158,627
1,183,593
3,805,532
6,844,213
4,872,898
397,381
566,032
848,052
52,528
397,167
-281,217
-206,906
-87,737
total shareholders funds
969,459
158,627
1,183,593
3,805,532
6,844,213
4,872,898
397,381
566,032
848,052
52,528
397,167
-281,217
-206,906
-87,737
Sep 2024
Sep 2023
Sep 2022
Sep 2021
Sep 2020
Sep 2019
Sep 2018
Sep 2017
Sep 2016
Sep 2015
Sep 2014
Jul 2013
Jul 2012
Jul 2011
Jul 2010
Operating Activities
Operating Profit
-2,124,767
-1,927,366
-2,646,172
-3,042,975
-3,534,657
-1,094,941
-295,357
-458,474
-302,719
-345,429
-271,429
-74,364
-119,169
-87,837
Depreciation
349
435
545
506
613
208
148
185
Amortisation
19,056
14,926
11,153
7,672
7,246
6,016
4,853
4,135
2,550
1,606
1,222
214
Tax
Stock
Debtors
-195,189
-1,577,256
339,382
811,266
849,815
38,513
43,211
66,949
4,202
-37,993
3,780
13,610
20,907
Creditors
-635,998
-76,347
825,104
-579,435
602,780
46,554
13,962
-31,222
-91,164
106,221
-372,860
406,503
9,144
399
Accruals and Deferred Income
-619,392
48,971
333,836
171,918
145,605
129,499
-11,943
-101,361
126,512
Deferred Taxes & Provisions
Cash flow from operations
-3,165,563
-362,125
-1,814,916
-4,253,580
-3,628,228
-951,177
-331,548
-653,686
-269,023
-199,609
-646,847
318,743
-130,932
-87,438
Investing Activities
capital expenditure
-100,331
-70,287
-56,259
-337,280
-24,493
-2,681
-15,655
-10,906
-27,085
-69,707
-31,879
-79,364
Change in Investments
cash flow from investments
-100,331
-70,287
-56,259
-337,280
-24,493
-2,681
-15,655
-10,906
-27,085
-69,707
-31,879
-79,364
Financing Activities
Bank loans
Group/Directors Accounts
-218,370
130,932
87,438
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
2,912,679
882,001
5,500,312
5,552,267
125,000
175,000
1,097,181
949,029
100
interest
22,920
20,399
24,233
4,294
5,660
18,191
1,706
1,454
1,062
790
784
53
1
cash flow from financing
2,935,599
902,400
24,233
4,294
5,505,972
5,570,458
126,706
176,454
1,098,243
790
949,813
-218,317
130,933
87,538
cash and cash equivalents
cash
-330,295
469,988
-1,846,942
-4,586,566
1,853,251
4,616,600
-220,497
-488,138
802,135
-268,526
271,087
21,062
100
overdraft
change in cash
-330,295
469,988
-1,846,942
-4,586,566
1,853,251
4,616,600
-220,497
-488,138
802,135
-268,526
271,087
21,062
100
medannex limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for medannex limited. Get real-time insights into medannex limited's credit score, group structure and payment trends.
Perform a competitor analysis for medannex limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in EH3 area or any other competitors across 12 key performance metrics.
medannex limited Ownership
MEDANNEX LIMITED group structure
Medannex Limited has no subsidiary companies.
Ultimate parent company
MEDANNEX LIMITED
SC363190
MEDANNEX LIMITED Shareholders
The largest shareholders in Medannex Limited include Morningside Venture Investments Limited and Christopher Barry Wood.
morningside venture investments limited
31.08%
christopher barry wood
23.52%
hugh stephen griffith
9.98%
scottish enterprise
9.27%
wilfred sydney hanna
4.06%
muriel hanna
2.91%
moira adamson
2.8%
keith lipman
2.38%
mark catton
1.94%
phil fretwell
1.13%
medannex limited directors
Medannex Limited currently has 7 directors.
The longest serving directors include
Prof Christopher Wood (Jun 2010) and
Dr Keith Lipman (Jul 2015).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to medannex limited.
medannex limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MEDANNEX LIMITED. This can take several minutes, an email will notify you when this has completed.
medannex limitedCompanies House Filings - See Documents
